Analytical Validation of an Automated Assay to Measure Calprotectin (S100A8/A9) in Dog Saliva and Serum and Changes in Canine Leishmaniasis, Pyometra and Hyperadrenocorticism

Overview

Journal BMC Vet Res

Publisher Biomed Central

Specialty Veterinary Medicine

Date 2025 Feb 20

PMID 39980018

Authors

Marina Garcia-Camacho

Asta Tvarijonaviciute

Silvia Martinez-Subiela

Jose Joaquin Ceron

Alberto Munoz-Prieto

Affiliations

Soon will be listed here.

Abstract

Background: Calprotectin (S100A8/A9) is a protein related to innate immunity that is considered a biomarker of inflammation. Currently, there is a commercially available automated assay for the measurement of calprotectin concentration (Bühlmann fCal Turbo assay), which has been previously validated for saliva and serum of swine and for saliva of horses, and in the canine species it has been validated for use with fecal samples, but it has not been previously validated in canine saliva or serum. Thus, the aim of this study was to perform an analytical validation of an automated assay for the measurement of calprotectin in the saliva and serum of dogs. In addition, changes in this protein in saliva and serum of three diseases with different pathogenic mechanisms - leishmaniasis, pyometra and hyperadrenocorticism - were evaluated. Finally, in these diseases, the correlation of salivary and serum calprotectin with the serum levels of three acute phase proteins (APPs), including C-reactive protein (CRP), haptoglobin (Hp) and ferritin, was also assessed.

Results: The analytical validation results showed that the assay was precise (coefficients of variation < 15% in all cases), accurate (the dilutional parallelism for serum and salivary calprotectin showed observed-to-expected ratios with a mean of 96.9% and 97.2%, respectively), and presented a limit of detection of 0.038 mg/L. When this assay was applied to the different diseases, a significant increase in the concentration of salivary calprotectin in dogs with leishmaniasis (p = 0.0002) and in those with pyometra (p = 0.002), compared to healthy ones, was observed, whereas no significant differences were found in serum. Furthermore, a significant positive moderate correlation was obtained between salivary calprotectin and serum CRP (r = 0.5; p = 0.001) and haptoglobin (r = 0.5; p = 0.002), and between calprotectin and CRP (r = 0.67; p < 0.001) in serum.

Conclusions: Calprotectin (S100A8/A9) can be measured in dog saliva and serum samples by the automated method validated in this study, and when measured in saliva it could be used as a potential biomarker of inflammation and immune activation in the dog.

References

Rawlinson J, Goldstein R, Reiter A, Attwater D, Harvey C . Association of periodontal disease with systemic health indices in dogs and the systemic response to treatment of periodontal disease. J Am Vet Med Assoc. 2011; 238(5):601-9. DOI: 10.2460/javma.238.5.601. View

Franco-Martinez L, Gelemanovic A, Horvatic A, Contreras-Aguilar M, Mrljak V, Ceron J . The Serum and Saliva Proteome of Dogs with Diabetes Mellitus. Animals (Basel). 2020; 10(12). PMC: 7760505. DOI: 10.3390/ani10122261. View

Munoz-Prieto A, Tvarijonaviciute A, Escribano D, Martinez-Subiela S, Ceron J . Use of heterologous immunoassays for quantification of serum proteins: The case of canine C-reactive protein. PLoS One. 2017; 12(2):e0172188. PMC: 5319752. DOI: 10.1371/journal.pone.0172188. View

Sanchez-Medrano A, Martinez-Martinez R, Soria-Guerra R, Portales-Perez D, Bach H, Martinez-Gutierrez F . A systematic review of the protein composition of whole saliva in subjects with healthy periodontium compared with chronic periodontitis. PLoS One. 2023; 18(5):e0286079. PMC: 10208468. DOI: 10.1371/journal.pone.0286079. View

Majster M, Almer S, Bostrom E . Salivary calprotectin is elevated in patients with active inflammatory bowel disease. Arch Oral Biol. 2019; 107:104528. DOI: 10.1016/j.archoralbio.2019.104528. View

Hsu K, Passey R, Endoh Y, Rahimi F, Youssef P, Yen T . Regulation of S100A8 by glucocorticoids. J Immunol. 2005; 174(4):2318-26. DOI: 10.4049/jimmunol.174.4.2318. View

Hagman R . Clinical and molecular characteristics of pyometra in female dogs. Reprod Domest Anim. 2013; 47 Suppl 6:323-5. DOI: 10.1111/rda.12031. View

Liu M, Lee J, Jung S, Ji S, Choi Y . Ability of S100 proteins and matrix metalloproteinase-9 to identify periodontitis in a ligature-induced periodontitis dog model. J Clin Periodontol. 2019; 47(2):182-192. DOI: 10.1111/jcpe.13215. View

Ceron J, Ortin-Bustillo A, Lopez-Martinez M, Martinez-Subiela S, Eckersall P, Tecles F . S-100 Proteins: Basics and Applications as Biomarkers in Animals with Special Focus on Calgranulins (S100A8, A9, and A12). Biology (Basel). 2023; 12(6). PMC: 10295460. DOI: 10.3390/biology12060881. View

10.

Jandel A, Heilmann R, Sander H, Steiner J, Grutzner N, Xenoulis P . Serum α-Proteinase Inhibitor, Calprotectin, and S100A12 Concentrations in the Characterization of Pancreatitis in Dogs. Vet Sci. 2023; 10(7). PMC: 10385135. DOI: 10.3390/vetsci10070428. View

11.

Hagman R, Jan Reezigt B, Bergstrom Ledin H, Karlstam E . Blood lactate levels in 31 female dogs with pyometra. Acta Vet Scand. 2009; 51:2. PMC: 2630309. DOI: 10.1186/1751-0147-51-2. View

12.

Munoz-Prieto A, Rubic I, Horvatic A, Baric Rafaj R, Ceron J, Tvarijonaviciute A . Metabolic profiling of serum from dogs with pituitary-dependent hyperadrenocorticism. Res Vet Sci. 2021; 138:161-166. DOI: 10.1016/j.rvsc.2021.06.011. View

13.

Heilmann R, Jergens A, Ackermann M, Barr J, Suchodolski J, Steiner J . Serum calprotectin concentrations in dogs with idiopathic inflammatory bowel disease. Am J Vet Res. 2012; 73(12):1900-7. DOI: 10.2460/ajvr.73.12.1900. View

14.

Heilmann R, Cranford S, Ambrus A, Grutzner N, Schellenberg S, Ruaux C . Validation of an enzyme-linked immunosorbent assay (ELISA) for the measurement of canine S100A12. Vet Clin Pathol. 2016; 45(1):135-47. DOI: 10.1111/vcp.12320. View

15.

Ceron J, Pardo-Marin L, Caldin M, Furlanello T, Solano-Gallego L, Tecles F . Use of acute phase proteins for the clinical assessment and management of canine leishmaniosis: general recommendations. BMC Vet Res. 2018; 14(1):196. PMC: 6011270. DOI: 10.1186/s12917-018-1524-y. View

16.

Enderle L, Koller G, Heilmann R . Verification of the fCAL turbo immunoturbidimetric assay for measurement of the fecal calprotectin concentration in dogs and cats. J Vet Diagn Invest. 2022; 34(5):813-824. PMC: 9446300. DOI: 10.1177/10406387221114031. View

17.

Lopez-Martinez M, Martinez-Subiela S, Ceron J, Ortin-Bustillo A, Ramis G, Lopez-Arjona M . Measurement of Calprotectin (S100A8/A9) in the Saliva of Pigs: Validation Data of A Commercially Available Automated Assay and Changes in Sepsis, Inflammation, and Stress. Animals (Basel). 2023; 13(7). PMC: 10092961. DOI: 10.3390/ani13071190. View

18.

Kim H, Karna S, Shin Y, Vu H, Cho H, Kim S . S100A8 and S100A9 in saliva, blood and gingival crevicular fluid for screening established periodontitis: a cross-sectional study. BMC Oral Health. 2021; 21(1):388. PMC: 8351418. DOI: 10.1186/s12903-021-01749-z. View

19.

Wang Z, Zheng G, Li G, Wang M, Ma Z, Li H . Methylprednisolone alleviates multiple sclerosis by expanding myeloid-derived suppressor cells via glucocorticoid receptor β and S100A8/9 up-regulation. J Cell Mol Med. 2020; 24(23):13703-13714. PMC: 7753844. DOI: 10.1111/jcmm.15928. View

20.

Money S . The Risks of Chronic Corticosteroid Exposure. J Pain Palliat Care Pharmacother. 2017; 31(2):160-161. DOI: 10.1080/15360288.2017.1298689. View